Age 50-59
Enlicitide (Lipfendra)
Well tolerated & effective · USD 330/mo · N/A-paid cash
Has to be taken on an empty stomach, so I take it first thing and wait before coffee.
Lipfendra is the first PCSK9 inhibitor taken as a daily pill, approved in 2026. Early experiences from people taking it.
Shared experiences, not medical advice. For decisions about your treatment, talk to your clinician.
Community snapshot
Not enough shared yet (N = 0).
Numbers appear once enough people have shared, so nobody can be singled out. The 1 case written by lipid.site is never counted.
Well tolerated & effective · USD 330/mo · N/A-paid cash
Has to be taken on an empty stomach, so I take it first thing and wait before coffee.
Statins and muscle painRepatha without insuranceEzetimibe (Zetia) experiencesLerochol (lerodalcibep) experiences